Will DAIA resolve the ambiguities of regulating in vitro clinical tests?
Are your Companion Diagnostic Partners Ready?
Why Diagnostics Have Trouble Finding Their Voice
Immunothrapy: Predicting response to targeted therapies and checkpoint inhibitors
The Dawn of Personalized Medicine: The Role of the Pharmacist
Preventative medicine: genetic screening of inherited diseases
Of mice and men: Strategies for humanization in preclinical immuno-oncology research
table of contents
Editors Notes
Field Notes
Will DAIA resolve the ambiguities of regulating in vitro clinical tests?
Are your Companion Diagnostic Partners Ready?
Why Diagnostics Have Trouble Finding Their Voice
Cognoscienti
Immunothrapy: Predicting response to targeted therapies and checkpoint inhibitors
The Dawn of Personalized Medicine: The Role of the Pharmacist
Precision Tools
Preventatie medicine: genetic screening of inherited diseases
Next-Generation-Sequencing Data for Mouse Models: Applications and analysis in context of a pre-clinical oncology drug development
Makingthe Shift from Technological Innovation to Operational Excellence: Delivering on the Promis Of Next-Generation Sequencing for Personalized Medicine
Snpshot
Of mice and men: Strategies for humanization in preclinical immuno-oncology research
Preparing for the New Possible: A Summar of the 14th Annual Personalized Medicine Conference at Harvard Medical School
Tweets
Only 72 hours left to register to hear how Texas Oncology is keeping up with Precision Medicine advances… https://t.co/WuuWhs2XJy, - New post: Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases https://t.co/oCMkrh10dL,
- New post: Sema4 Introduces “Sema4 Signal™”, a New Family of Products and Services Delivering Data-driven Precision O https://t.co/IbcX78peOv,